Anticancer Drugs Durvalumab Oncology Pharmacology Physiotherapy

Durvalumab (Warnings-23)

In this article we will discuss Durvalumab (Warnings-23)

In this article, we will discuss Durvalumab (Warnings-23). So, let’s get started.

Type 1 Diabetes Mellitus which can present with diabetic ketoacidosis: Monitor patients for hyperglycemia or other signs and symptoms of diabetes. Initiate treatment with insulin as clinically indicated. Withhold or permanently discontinue Durvalumab based on the severity.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.